A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

NCT00460421 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Palifermin
RADIATION: Total Body irradiation
DRUG: Chemotherapy

Sponsor

Swedish Orphan Biovitrum